Pharmaceutical companies operate in one of the most dynamic environments. Changes in regulations by leading bodies such as US Food and Drug Administration (USFDA) and the European Medicines Agency (EMA) have increased the significance of regulatory compliance management for drug manufacturers.
PPSI can efficiently and proactively help to maneuver the daily changing environment.
Bringing one new drug to the public typically costs a pharmaceutical or biotechnology company on average more than $1 billion and takes an average of 10 to 15 years. Our comprehensive portfolio of services, spanning preclinical through post-approval, features integrated laboratory, Phase I-IV and consulting services to provide end-to-end solutions.
We build solid programs and solve complex clinical trial problems for pharmaceutical and biotech companies such as resource challenges and complications arising from mid-study changes.
Our project management team understands your needs and wants to help you succeed.